Evidence map›Paper›PMID 41141807›Full record

ArticleACS omega2025

Lectin from

Adrielle Rodrigues Costa, Renato Rodrigues Roma, Abel Vieira de Melo Bisneto, Felipe Eduardo Alves De Paiva, Jefferson Hollanda Véras, Juliana Santana De Curcio, Lívia Do Carmo Silva, Lee Chen-Chen, Cléver Gomes Cardoso, Elisângela de Paula Silveira-Lacerda and 1 more

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Antitumor effects of a lectin purified fromFrontiers in oncology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Adrielle Rodrigues CostaMedicine Department, Regional University of Cariri - URCA, Crato, CE 63048-080, Brazil.
Renato Rodrigues RomaCenter for Agricultural Sciences and Biodiversity, Federal University of Cariri, Crato, CE 74605-220, Brazil.
Abel Vieira de Melo BisnetoLaboratory of Radiobiology and Mutagenesis, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.
Felipe Eduardo Alves De PaivaLaboratory of Radiobiology and Mutagenesis, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.
Jefferson Hollanda VérasLaboratory of Radiobiology and Mutagenesis, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.
Juliana Santana De CurcioLaboratory of Molecular Genetics and Cytogenetics, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.
Lívia Do Carmo SilvaLaboratory of Molecular Genetics and Cytogenetics, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.
Lee Chen-ChenLaboratory of Radiobiology and Mutagenesis, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.ORCID https://orcid.org/0000-0002-5436-5799
Cléver Gomes CardosoLaboratory of Radiobiology and Mutagenesis, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.ORCID https://orcid.org/0000-0002-9175-7695
Elisângela de Paula Silveira-LacerdaLaboratory of Molecular Genetics and Cytogenetics, Department of Genetics, Institute of Biological Sciences, Federal University of Goiás, 74690-900 Goiânia, Brazil.ORCID https://orcid.org/0000-0002-4143-9007
Claudener Souza TeixeiraMedicine Department, Regional University of Cariri - URCA, Crato, CE 63048-080, Brazil.ORCID https://orcid.org/0000-0002-9792-0369

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis plays a vital role in tumor development, and its inhibition, along with selective cytotoxicity, represents a promising strategy for cancer treatment. Lectins, carbohydrate-binding proteins, have demonstrated dual potential in blocking angiogenesis and selectively targeting tumor cells. This study investigates the antiangiogenic and cytotoxic properties of

Identifiers

PMID41141807
PMCPMC12547575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.